Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860041 · ClinicalTrials.gov registry record
Acute Pain Caused by Paclitaxel in Patients With Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 306
- Enrollment target
NCT00860041 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 306 participants.
The verdict
NCT00860041 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information over time from patients receiving paclitaxel for cancer may help doctors learn more about pain caused by paclitaxel and plan the best treatment. PURPOSE: This clinical trial is studying acute pain caused by paclitaxel in patients with cancer.
Interventions
- BEHAVIORAL pain questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00860041
The ClinicalTrials.gov registry entry for NCT00860041 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pain questionnaires is the first listed.
NCT00860041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00860041 about?
NCT00860041 is a clinical study titled "Acute Pain Caused by Paclitaxel in Patients With Cancer". RATIONALE: Gathering information over time from patients receiving paclitaxel for cancer may help doctors learn more about pain caused by paclitaxel and plan the best treatment. PURPOSE: This clinical trial is studying acute pain caused by paclitaxel in patients with cancer.
What is the current status of trial NCT00860041?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2009-02. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00860041?
The interventions under investigation include: pain questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00860041?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.